New York, 10016, NY,
United States
Bristol-Myers Squibb United States Technographics
Discover the latest software purchases and digital transformation initiatives being undertaken by Bristol-Myers Squibb United States and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 32000 Bristol-Myers Squibb United States employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Bristol-Myers Squibb United States has purchased the following applications: IQVIA FIA for Insurance Claims Management in 2025 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Bristol-Myers Squibb United States is running and its propensity to invest more and deepen its relationship with IQVIA or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Bristol-Myers Squibb United States revenues, which have grown to $46.30 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Bristol-Myers Squibb United States intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
ERP Services and Operations
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| IQVIA | Legacy | IQVIA FIA | Insurance Claims Management | ERP Services and Operations | n/a | 2025 | 2025 |
In 2025 Bristol-Myers Squibb United States deployed IQVIA FIA to power its COBENFY US prescription coverage and out of pocket estimate capabilities. The deployment positions IQVIA FIA as an Insurance Claims Management platform supporting market access and patient access workflows while surfacing claims approval and out of pocket distribution metrics for web‑facing coverage lookup and estimates.
IQVIA FIA is configured to deliver payer and adjudication analytics, claims approval reporting, and out of pocket calculation services that feed the COBENFY coverage tool. Functional capabilities implemented include claims approval metrics, out of pocket distribution reporting, and coverage determination logic aligned to payer adjudication analytics typical of Insurance Claims Management systems.
The implementation integrates IQVIA FIA outputs into the COBENFY US prescription coverage and out of pocket estimates workflow, with the COBENFY coverage tool citing IQVIA FIA for claims approval and out of pocket distribution metrics for the latest 4 weeks ending 03/28/2025. Operational coverage is focused on US market access and patient access teams and on reporting use cases where payer adjudication visibility is required.
Governance is centered on operationalizing FIA driven analytics within market access and patient access reporting processes, enabling consistent claim approval and out of pocket statistics to be consumed by the COBENFY tool and related reporting pipelines. IQVIA FIA is explicitly used for payer adjudication analytics in the US market and for driving the COBENFY prescription coverage and out of pocket estimate outputs.
|
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||